Back
Novavax Vs. BioCryst Pharmaceuticals Industry Stock Comparison
Buy
54
NVAX
Novavax
Last Price:
13.29
Seasonality Move:
1.12%
Sell
33
BCRX
BioCryst Pharmaceuticals
Last Price:
7.62
Seasonality Move:
-0.13%
Buy
54
Novavax (NVAX)
is a Buy
Is Novavax a Buy, Sell or Hold?
- The current Novavax [NVAX] share price is $13.30. The Score for NVAX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- NVAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.62. The Score for BCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCRX is experiencing slight selling pressure.
NVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 54.89 | Buy |
Chaikin Money Flow: | 5104422 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.68 - 13.02) | Buy |
Bollinger Bands (100): | (10.83 - 15.87) | Sell |
BCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 43.3 | Sell |
Chaikin Money Flow: | -533161 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.68 - 8.32) | Sell |
Bollinger Bands (100): | (6.22 - 7.92) | Buy |
NVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.7 | Buy |
20-day SMA: | 12.58 | Buy |
50-day SMA: | 12.79 | Buy |
200-day SMA: | 8.99 | Buy |
8-day EMA: | 12.72 | Buy |
20-day EMA: | 12.61 | Buy |
50-day EMA: | 12.62 | Buy |
200-day EMA: | 10.88 | Buy |
BCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.8 | Sell |
20-day SMA: | 7.92 | Sell |
50-day SMA: | 7.8 | Sell |
200-day SMA: | 6.24 | Buy |
8-day EMA: | 7.73 | Sell |
20-day EMA: | 7.84 | Sell |
50-day EMA: | 7.65 | Sell |
200-day EMA: | 6.83 | Buy |
Novavax Earnings Growth & NVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.92 per share, and an increase next year of $0.88 per share.
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
Novavax Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioCryst Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |